GC BIOPHARMA

Live / Registered — Registered (as of 24 Feb 2026)

What this means for you

Registered since 24 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97298515
Registration number
8152205
Mark type
Design + words
Filed
07 Mar 2022
Published for opposition
13 Dec 2022
Registered
24 Feb 2026
Attorney of record
Kwang Yup Chae

Goods and services

  • Class 005 — Pharmaceuticals: Medicines for humans used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors
  • Class 042 — Scientific and technological services: Research and development of medicines; Research and development, scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Scientific research in the fields of biomedicine; Research and development in the pharmaceutical and biotechnology fields

Owner

Prior registrations

Prosecution history

  • 24 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 24 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
  • 05 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 05 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 05 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 05 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 05 Feb 2026 — ASSIGNED TO LIE
  • 29 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 14 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 14 Nov 2025 — NON-FINAL ACTION E-MAILED
  • 14 Nov 2025 — SU - NON-FINAL ACTION - WRITTEN
  • 10 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 08 May 2025 — USE AMENDMENT FILED
  • 10 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 08 May 2025 — TEAS STATEMENT OF USE RECEIVED

View this trademark record on Marksy